Peptest & Reflux Updates
Throat problems? Peptest reveals the top reflux-related symptom worries
Peptest, a home reflux diagnostic service, has highlighted the severity of symptoms presented by individuals seeking self-diagnosis.read moreReflux disease and vocal fold polyps (VFPs)
A new study has used Peptest to explore the relationship between gastro-oesophageal reflux disease (GORD/ GERD) and vocal fold polyps.read morePeptest is a ‘good screening test’ for detecting laryngopharyngeal reflux (LPR)
Peptest is a ‘good screening test’ for medical professionals, such as GPs, allergists, ENT specialists, gastroenterologists and chest physicians, to detect laryngopharyngeal reflux (LPR).read moreSeverity of GERD ‘related to highest pepsin concentration’
The severity of gastro-oesophageal reflux disease is related to the lowest pH and the highest pepsin concentration in gastric juice, study reveals.read moreH. pylori and GERD (reflux disease)
Is there a connection between Helicobacter pylori and gastro-oesophageal reflux disease (GERD)? Some suggest that people with H. pylori are less likely to have GERD, whereas some are...read moreMucus in the throat and reflux
Excess mucus in the throat is frequently cited as a common symptom of patients who are later diagnosed with reflux disease.read moreReflux disease and Barrett’s Oesophagus
When gastro-oesophageal reflux disease happens on a regular basis for a long period of time it can lead to Barrett’s Oesophagus.read moreDoes PPI usage increase risk of gut bug C. difficile?
Multiple studies have shown a statistically significant link between use of proton pump inhibitor medications (PPIs) and Clostridium difficile infections.read moreReflux disease may ‘contribute to the development of lung fibrosis’
The odds of having gastro-oesophageal reflux disease (GORD/GERD) is nearly two times higher in patients with idiopathic pulmonary fibrosis (IPF) compared with adults without...read more
Professor Peter Dettmar Co-Edits Annals of Esophagus Special
Professor Peter Dettmar and Professor Jeffery Pearson, world renowned experts in pepsin, will present key papers on gastroesophageal reflux disease in an international journal.read moreGERD review by Professor Dettmar in Annals of Esophagus
Professor Peter Dettmar has shared insight into how prevalent gastroesophageal reflux disease (GERD) is across the world in an article published in the international...read morePhysiotherapists at NHS Hospital use Peptest in respiratory clinics
Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary.read morePeptest at laryngopharyngeal reflux symposium in China
Peptest and the importance of salivary pepsin detection was put under the spotlight at a forum in China, attended by our distributor Maxhealth.read morePeptest in virtual conference of China gastro experts
Professor Peter Dettmar has provided insight into the diagnosis and treatment of reflux disease to a virtual conference of key opinion leaders in China.read moreCould Peptest help triage non-urgent reflux cases?
Peptest could prove useful during the current Covid-19 pandemic when access to clinics and more complex clinical diagnostic procedures is restricted or delayed.read moreRestech unveils ‘PepsinCheck by Peptest’ in the US
Restech, our distribution partner in the US, has launched a branded version of our reflux diagnostic saliva test – known as ‘PepsinCheck by Peptest’.read morePeptest labs to reopen for reflux testing
We’re delighted to announce that the Peptest laboratories will reopen for testing of saliva samples for pepsin on Monday 25 May. During the coronavirus...read moreCovid-19: a coronavirus update
In these difficult times with the Covid-19 (Coronavirus) outbreak, to protect our staff members, the majority of the RD Biomed and Peptest team will...read more
Reflux disease and vocal fold polyps (VFPs)
A new study has used Peptest to explore the relationship between gastro-oesophageal reflux disease (GORD/ GERD) and vocal fold polyps.read morePeptest is a ‘good screening test’ for detecting laryngopharyngeal reflux (LPR)
Peptest is a ‘good screening test’ for medical professionals, such as GPs, allergists, ENT specialists, gastroenterologists and chest physicians, to detect laryngopharyngeal reflux (LPR).read moreSeverity of GERD ‘related to highest pepsin concentration’
The severity of gastro-oesophageal reflux disease is related to the lowest pH and the highest pepsin concentration in gastric juice, study reveals.read morePhysiotherapists at NHS Hospital use Peptest in respiratory clinics
Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary.read morePeptest could help eliminate unnecessary use of PPIs
Measuring salivary pepsin levels has the potential to reduce time to diagnose acid reflux, minimise the use of proton pump inhibitor (PPI) therapy, and...read moreSelf-referral reflux test using Peptest
Peptest is a useful, non-invasive diagnostic test for self-diagnosing reflux related symptoms, a study published in the EC Gastroenterology and Digestive System journal has...read moreStudy compares ‘simpler’ Peptest to ‘invasive’ 24-hour pH monitoring
Salivary pepsin detection is hailed a ‘simpler, more cost-effective and less traumatic universal first-line alternative’ to 24-hour pH monitoring in diagnosing laryngopharyngeal reflux disease...read moreEye exams could help reflux patients
Eye examinations could improve the management of patients with laryngopharyngeal reflux disease (LPR), according to a new study.read moreStudy says Peptest is ‘useful for LPR diagnosis’
Laryngopharyngeal reflux (LPR), when gastric contents refluxes into the larynx/pharynx, can be diagnosed using a salivary pepsin test, researchers say.read more
Throat problems? Peptest reveals the top reflux-related symptom worries
Peptest, a home reflux diagnostic service, has highlighted the severity of symptoms presented by individuals seeking self-diagnosis.read moreH. pylori and GERD (reflux disease)
Is there a connection between Helicobacter pylori and gastro-oesophageal reflux disease (GERD)? Some suggest that people with H. pylori are less likely to have GERD, whereas some are...read moreMucus in the throat and reflux
Excess mucus in the throat is frequently cited as a common symptom of patients who are later diagnosed with reflux disease.read moreReflux disease and Barrett’s Oesophagus
When gastro-oesophageal reflux disease happens on a regular basis for a long period of time it can lead to Barrett’s Oesophagus.read moreDoes PPI usage increase risk of gut bug C. difficile?
Multiple studies have shown a statistically significant link between use of proton pump inhibitor medications (PPIs) and Clostridium difficile infections.read moreReflux disease may ‘contribute to the development of lung fibrosis’
The odds of having gastro-oesophageal reflux disease (GORD/GERD) is nearly two times higher in patients with idiopathic pulmonary fibrosis (IPF) compared with adults without...read moreProton Pump Inhibitor Use Linked to Increased Asthma Risk in Children
Children that take proton pump inhibitors medication (PPIs) are more likely to have asthma than those that don’t, a study published in JAMA Pediatrics...read moreVolunteers wanted for study into trigger foods for reflux
Do you suffer from reflux-related symptoms? Northumbria University is looking for recruits to take part in a study investigating foods that trigger reflux and...read moreDiet and lifestyle can impact reflux symptoms in women
Regular exercise and healthier diets may reduce symptoms of reflux (GERD/GORD) substantially for some women and could even make medication unnecessary - a new...read more
Peptest could help eliminate unnecessary use of PPIs
Measuring salivary pepsin levels has the potential to reduce time to diagnose acid reflux, minimise the use of proton pump inhibitor (PPI) therapy, and...read moreDiet and lifestyle can impact reflux symptoms in women
Regular exercise and healthier diets may reduce symptoms of reflux (GERD/GORD) substantially for some women and could even make medication unnecessary - a new...read moreWhat is the RefluxStop implant?
Medtech firm Implantica says its new RefluxStop device for treating acid reflux can ‘eliminate the need for proton-pump inhibitors (PPIs)’.read moreWhat is Stretta therapy for treating reflux?
The Stretta system uses a special catheter or tube to deliver low-power and low-temperature radiofrequency energy to the muscle tissues in the LOS.read moreWhat is alkaline water and can it help with reflux?
Alkaline water – water that has been treated to have a higher pH level than most tap and bottled water – is rising in...read moreProton Pump Inhibitors (PPIs) Explained
Proton pump inhibitors (PPIs) are one of the most commonly prescribed medications in the world - here's our at-a-glance guide to PPIs.read moreIQoro: could this oral device help treat reflux?
Iqoro - a device that helps to strengthens the oesophagus and diaphragm - has been recognised by the NHS healthcare watchdog for relieving symptoms...read moreCan cashew gum help tackle reflux?
A new study ‘Cashew gum, a biopolymer, topically protects oesophageal mucosa in nonerosive reflux disease: A promising translational study’ has looked at whether cashew...read moreZantac heartburn drugs recalled: what you need to know
Doctors in the UK have been told to stop prescribing four types of a heartburn medication called Zantac or ranitidine as a ‘precautionary measure’.read more
Peptest™ is a single use in-vitro diagnostic device not for ingestion. It conforms to the European Directive 98/79/EC on in-vitro Diagnostic Medical Devices; this is shown by the CE mark of conformity.
Peptest™ kits are manufactured in the UK by RDBiomed Limited - a private limited company registered in England and Wales with number 06979218.
RDBiomed Limited
Daisy Building (2nd Floor)
Castle Hill Hospital
Castle Road
Cottingham
HU16 5JQ, UK
VAT Number: GB 990 1918 96
Follow
